Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathleen Dekeister

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Investigational New Drugs|July 31, 2016
Sunitinib-induced sudden hearing lossKathleen Dekeister, Emmanuelle Graillot, Mickaël Durbec, et al.
Case Reports in Oncology|May 20, 2016
Urachal Carcinoma with Choroidal, Lung, Lymph Node, Adrenal, Mammary, and Bone Metastases and Peritoneal Carcinomatosis Showing Partial Response after Chemotherapy Treatment with a Modified Docetaxel, Cisplatin and 5-Fluorouracil RegimenKathleen Dekeister, Jean Louis Viguier, Xavier Martin, et al.
Cancer Chemotherapy and Pharmacology|June 6, 2020
Validation of an online tool for early prediction of the failure-risk in gestational trophoblastic neoplasia patients treated with methotrexateKathleen Dekeister, Pierre-Adrien Bolze, Michel Tod, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Investigational New Drugs|July 31, 2016
Sunitinib-induced sudden hearing lossKathleen Dekeister, Emmanuelle Graillot, Mickaël Durbec, et al.
Case Reports in Oncology|May 20, 2016
Urachal Carcinoma with Choroidal, Lung, Lymph Node, Adrenal, Mammary, and Bone Metastases and Peritoneal Carcinomatosis Showing Partial Response after Chemotherapy Treatment with a Modified Docetaxel, Cisplatin and 5-Fluorouracil RegimenKathleen Dekeister, Jean Louis Viguier, Xavier Martin, et al.
Cancer Chemotherapy and Pharmacology|June 6, 2020
Validation of an online tool for early prediction of the failure-risk in gestational trophoblastic neoplasia patients treated with methotrexateKathleen Dekeister, Pierre-Adrien Bolze, Michel Tod, et al.
Pageof 1